IRCT20210901052360N1招募中3 期
Clinical trial of the effect of Silymarin on blood and imaging biomarkers of Alzheimer's patients with dyslipidemia
适应症
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 入组人数
- 36
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 60 years 至 80 years（—）
- 性别
- All
入选标准
- •The patient has sporadic Alzheimer's disease.
- •The patient has a mild degree of Alzheimer's disease.
- •The patient has dyslipidemia.
- •Patients whose Alzheimer's disease has been confirmed by clinical evaluation or imaging techniques and biochemical tests by a neurologist.
排除标准
- •The patient has no history of viral hepatitis.
- •The patient has not had alcohol misuse, smoking or drug abuse in the last month.
- •The patient should not take chemotherapy drugs.
- •The patient does not have active rheumatic disorders.
- •The patient does not have diabetes and uncontrolled hypertension.
- •The patient has no history of brain surgery.
- •The patient does not have advanced heart failure, acute cardiovascular disease, or chronic renal failure.
- •The patient does not have hypothyroidism.
研究者
相似试验
尚未招募
3 期
Effect of silymarin in inflammatory bowel diseaseK50-K52Inflammatory Bowel Disease.Noninfective inflammatory bowel diseaseIRCT20101107005123N3Mashhad University of Medical Sciences40
已完成
1 期
Evaluation of the effect of silymarin on blood sugar profile(FBSand 2hpp ) and HbA1C in patients with type 2 diabetes mellitusIRCT20170814035697N5Oroumia University of Medical Sciences50
招募中
3 期
Silymarin in multiple SclerosisTherapeutic effect of silymarin.IRCT20171220037977N1Esfahan University of Medical Sciences60
已完成
3 期
The effect of silymarin on methadone poisoningIRCT20210216050377N1Shahre-kord University of Medical Sciences64
已完成
2 期
To evaluate the effectiveness of Silymarin (Livergol) on IL-6 levels and size of endometrioma lesionsIRCT20150905023897N5Vice chancellor for research Tarbiat Modares University60